Waltham, MA, United States of America

Louis Renzetti

USPTO Granted Patents = 2 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Louis Renzetti: Innovator in Pharmaceutical Chemistry

Introduction

Louis Renzetti is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target various diseases. With a total of 2 patents to his name, Renzetti's work is paving the way for innovative treatments.

Latest Patents

Renzetti's latest patents include the development of substituted spirocyclic inhibitors of autotaxin. These inventions relate to compounds that are designed to treat a range of conditions, including cancer, lymphocyte homing, chronic inflammation, neuropathic pain, fibrotic diseases, thrombosis, and cholestatic pruritus. The compounds are characterized by their unique formula and are accompanied by pharmaceutically acceptable salts, synthesis methods, intermediates, and formulations.

Career Highlights

Throughout his career, Louis Renzetti has been associated with X-rx, Inc., where he has been instrumental in advancing research and development in pharmaceutical applications. His expertise in creating innovative compounds has positioned him as a key figure in the industry.

Collaborations

Renzetti has collaborated with notable colleagues, including Lee Babiss and Matthew Clark. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the field.

Conclusion

Louis Renzetti's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an innovator in the industry. His work continues to influence the development of new treatments for various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…